Annual report
4563.TEDINET S100XTMQ
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks20 of 20 passed
Key figures · 125
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥5.1bn | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | −¥9.1bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | −¥5.3bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥7.5bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥5.7bn | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥14.6bn | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥13.6bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥5.2bn | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥27.6bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥5.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥28.1bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥7.4bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥14.7bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥13.7bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥5.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | −¥28.1bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥5.4bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥4.7bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥28.9bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥38.8bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥45.5bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥2.5bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.1bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥26.1bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥30.4bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥38.6bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.0bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥17.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥5.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥6.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥8.7bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥11.2bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥11.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥19m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥131m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥357m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥97m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥155m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥5.9bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.2bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.0bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.6bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥17.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-14.44 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-119.53 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-39.29 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-94.29 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-92.86 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥7.67 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥7.17 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥131.04 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥169.77 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥251.81 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 55.2% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.0% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.0% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.1% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.8% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 56 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 55 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 145 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 138 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 131 | at 2021-12-31d | Cons. | Number of employees |
| Operating income | −¥4.4bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | −¥4.9bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | −¥4.5bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥3.1bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.0bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥8.0bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥7.9bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥5.7bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥39.3bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | −¥5.7bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | −¥39.3bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥8.1bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥8.1bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.4bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.7bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥38.7bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥40.7bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥44.9bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.7bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥37.3bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥34.1bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥38.7bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-15.95 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-167.03 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.64 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-52 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.91 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.49 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥6.62 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥8.03 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥187.33 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥190.57 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥252.16 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 58.2% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.4% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.1% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.6% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.0% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.0% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 389,026,550 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 286,377,550 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 198,470,300 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 178,623,900 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 153,072,400 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 35 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 33 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 40 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 39 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 42 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2025-12-31 | 56 pure |
| Pharmaceutical Businessreportable segment | employees | at 2025-12-31 | 35 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,378
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)野 田 智 也 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高 島 稔 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)HGF遺伝子治療用製品の原材料の評価 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結財務諸表の注記事項(重要な会計上の見積り) | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)野 田 智 也 | |
| Cpa3 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)高 島 稔 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)HGF遺伝子治療用製品の原材料の評価 | |
| Same as kam for consolidated fskam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Business revenue (5-year summary) | Prior4YearDuration | 64148000 | JPY |
| Business revenue (5-year summary) | Prior3YearDuration | 67061000 | JPY |
| Business revenue (5-year summary) | Prior2YearDuration | 152985000 | JPY |
| Business revenue (5-year summary) | Prior1YearDuration | 643638000 | JPY |
| Business revenue (5-year summary) | CurrentYearDuration | 874120000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | -13588973000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | -14610015000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | -5651225000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -7537856000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | -5288775000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | -13675587000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | -14714772000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | -7437607000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -28128983000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | -5123269000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | -11547856000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | -11794586000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | -6382287000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -28236534000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | -5015166000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 38634741000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 30425406000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 26103166000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 2156591000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 3076080000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 45455746000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 38820711000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 20 of 20 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |